Advertisement

Cytotechnology

, Volume 71, Issue 1, pp 15–22 | Cite as

4-Hydroxyderricin inhibits osteoclast formation and accelerates osteoblast differentiation

  • Hiromi HagiwaraEmail author
  • Kyoko Nakata
  • Hitoshi Miyazaki
  • Sanae Maehashi
  • Yuki Komiyama
  • Rieko Aida
  • Shigeki Yoshida
  • Daichi Kokubu
  • Keitaro Hagiwara
  • Kaoru Yoshida
Open Access
Article
First Online:
  • 231 Downloads

Abstract

4-Hydroxyderricin (4-HD) is a major polyphenol of Angelica keiskei (Japanese name Ashitaba), exhibiting anti-allergic, anti-diabetic, anti-oxidant, and antitumor effects. The present study was designed to evaluate the effects of 4-HD on bone formation and maintenance by using cultured osteoclasts and osteoblasts. 4-HD did not affect cell proliferation of stromal ST2 cells and preosteoblast MC3T3-E1 cells at concentrations of 1–10 μM. This compound inhibited the formation of multinucleated osteoclasts from mouse splenic cells, and we identified a molecular pathway of osteoclast differentiation mediated by 4-HD, which led to inhibition of the expression of receptor activator of nuclear factor-κB ligand and macrophage-colony stimulating factor in ST2 cells. By contrast, 4-HD enhanced indices of osteoblast differentiation, such as alkaline phosphatase activity and calcium deposition by osteoblastic MC3T3-E1 cells, at concentrations of 1–10 μM. Furthermore, we found that 4-HD at 1 μM attenuated H2O2 levels in MC3T3-E1 cells. Our findings indicate that 4-HD may have critical effects on bone formation and maintenance.

Keywords

4-Hydroxyderricin Polyphenol Osteoblast Osteoclast Bone 

Introduction

Both the formation and maintenance of bone are controlled by bone-resorbing osteoclasts and bone-forming osteoblasts. Osteoclasts are multinucleated giant cells with the ability to resorb mineralized tissues. They are formed from hematopoietic cells of the monocyte/macrophage lineage (Udagawa et al. 1990). The development of osteoclasts in culture is strictly dependent on support provided by osteoblasts and/or stromal cells (Udagawa et al. 1990). The formation and activation of osteoclasts are controlled by the combined actions of receptor activator of nuclear factor-κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). Here, we formed multinucleated osteoclasts from splenic cells by co-culture with stromal ST2 cells that had been stimulated by activated vitamin D3 (Hagiwara et al. 2008, 2015; Notoya et al. 2007). Bone formation involves a complex series of events that include the proliferation and differentiation of osteoprogenitor cells, resulting in the formation of a mineralized extracellular matrix. The deposition of calcium and the sequential expression of type I collagen, alkaline phosphatase, and osteocalcin are known as markers of osteoblastic differentiation. Several model systems have been developed for studying the proliferation and differentiation of bone-forming cells in vitro and the molecular biology of the mineralization process, such as preosteoblastic cells from mouse calvariae (MC3T3-E1 cells) and osteoblast-like cells from rat calvariae (Bredford et al. 1993; Hagiwara et al. 1996; Liu et al. 1994; Stein et al. 1990). An imbalance of activities between osteoclasts and osteoblasts leads to bone metabolic diseases such as osteoporosis and osteopetrosis.

4-Hydroxyderricin (4-HD) (Fig. 1) is more abundant as aglycone forms, with relative abundances of 1.5% in the stem exudates of Angelica keiskei (Japanese name, Ashitaka). A number of studies have shown that this compound possess biological properties, including antidiabetic (Li et al. 2016; Zhang et al. 2015; Enoki et al. 2007), anti-inflammatory (Yasuda et al. 2014; Yadav et al. 2011) and antitumor (Sumiyoshi et al. 2015; Akihisa et al. 2011; Kimura et al. 2004; Okuyama et al. 1991) activities. However, little information is available on the effects of 4-HD on bone metabolism. The present study was designed to evaluate the in vitro effects of 4-HD on the formation and maintenance of bone by using cultured mouse cells. Our results indicate that 4-HD is useful in the prevention and treatment of osteoporosis.
Fig. 1

Structure of 4-HD

Materials and methods

Purification of 4-HD from Angelica keiskei

Chalcone-rich powder of Angelica keiskei (Ashitaba in Japanese) was purchased from Japan Bio Science Laboratory Co., Ltd (Osaka, Japan). The powder (2 g) was extracted with 100 ml of ethyl acetate at room temperature for 1 h. The extract was subjected to silica gel chromatography equilibrated with hexane/ethyl acetate (3:1, v/v), and eluted with hexane/ethyl acetate (1:1, v/v). The eluate containing 4-HD was subjected to ODS chromatography (Cosmosil C-18 OPN, Nacalai Tesque, Kyoto, Japan) equilibrated with 100% methanol to give pure 4-HD.

Formation of osteoclastic cells

Multinucleated osteoclastic cells were formed from spleen cells by co-culture with ST2 cells (RIKEN Cell Bank, Tsukuba, Japan) that had been stimulated by 100 nM 1α, 25-dihydroxy-vitamin D3 [1α, 25(OH)2 vitamin D3] (Wako Pure Chemical Industries, Ltd., Osaka, Japan). ST2 cells (2 × 104 cells/well) in 48-well plates (area of each well, 0.75 cm2) were pre-cultured with 100 nM 1α, 25(OH)2 vitamin D3 for 1 day to express RANKL. Spleen cells were collected from the splenic tissues of 6-weeks-old male ddY mice (Sankyo Labo Service, Tokyo, Japan). Erythrocytes contaminating the spleen cell fraction were eliminated by adding 0.83% ammonium chloride in 10 mM Tris–HCl (pH 7.4) to the cell pellet. Mouse spleen cells (1 × 105 cells/well) were spread on ST2 cell layers in 48-well plates and cultured in α-Modified minimum essential medium (α-MEM: Technologies, Inc. Grand Island, NY, USA), supplemented with 10% fetal bovine serum (Moregate BioTech, Bulimba, Australia), 50 units mL−1 penicillin and 50 μg mL−1 streptomycin (Life Technologies, Inc., Grand Island, NY, USA), in a humidified atmosphere of 5% CO2 in air at 37 °C for 7 days. Cultures were maintained at 37 °C in a humidified atmosphere of 5% CO2 in air. Fresh medium, 100 nM 1α, 25(OH)2 vitamin D3 and 4-HD were supplied at 2-days intervals. The Institutional Animal Care and Use Committee of Toin University of Yokohama approved all animal protocols and procedures.

Multinucleated osteoclastic cells formed were fixed in 3.7% formaldehyde for 5 min and then in a mixture of ethanol and acetone (1:1; v:v) for 1 min. These cells were then stained for tartrate resistant acid phosphatase (TRAP) activity (Udagawa et al. 1990). TRAP activity is a marker of multinucleated osteoclasts. TRAP-positive multinucleated cells (five or more nuclei) were counted under a microscope (IX70; Olympus, Tokyo, Japan).

Osteoblastic cell cultures

Preosteoblastic MC3T3-E1 cells were obtained from RIKEN Cell Bank (Tsukuba, Japan). Cells were maintained in a 55-cm2 dish in α-Modified minimum essential medium (α-MEM), supplemented with 10% fetal bovine serum, 50 units mL−1 penicillin and 50 μg mL−1 streptomycin, in a humidified atmosphere of 5% CO2 in air at 37 °C. After reaching 70% confluence, cells were detached by treatment with 0.05% trypsin, replated in either 55-cm2 dishes or 12-well plates (area of each well, 3.8 cm2) at a density of 1 × 104 cells/cm2, and grown in α-MEM supplemented with 10% fetal bovine serum, 50 units mL−1 penicillin, 50 μg mL−1 streptomycin, 5 mM β-glycerophosphate, and 50 μg mL−1 ascorbic acid. Fresh medium and 4-HD were supplied to cells at 2-days intervals. MC3T3-E1 cells formed nodules, and mineralization of nodules was observed after cultivation for 2–3 weeks.

Toxicity of 4-HD for cells

ST2 cells and MC3T3-E1 cells were replated in 96-well plates (area of each well, 0.32 cm2) at a density of 2.5 × 103 cells/cm2 and grown in α-MEM supplemented with 10% fetal bovine serum, 50 units mL−1 penicillin, 50 μg mL−1 streptomycin, and 4-HD at various concentrations. After subculture for 53 or 74 h, the cell layers were washed with RPMI 1640 medium (Life Technologies, Inc., Grand Island, NY, USA). 3-[4, 5-Dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT; DOJINDO, Kumamoto, Japan) reagent (0.5 mg mL−1 RPMI 1640) was added to each well, followed by incubation for 4 h for formazan formation. After the medium was removed, dimethyl sulfoxide was added to each well to dissolve the formazan, and absorbance was measured at 570 nm.

Measurement of intracellular reactive oxygen species

Intracellular reactive oxygen species were measured using the oxidant-sensitive probe 2′, 7′-dichlorofluorescin diacetate (DCFH-DA). MC3T3-E1 cells (4 × 104 cells/dish) in 3.5-cm dishes were cultured for 48 h with subsequent 48-h incubation with 4-HD. Thereafter, cells were incubated with 50 μM DCF-DA for 30 min followed by a 30-min incubation with 500 μM H2O2 and washed with Hank’s Balanced Salt Solution. Fluorescence emission was detected by confocal laser scanning microscopy at excitation and emission wavelengths of 488 and 505 nm, respectively. Images were analyzed using a confocal scanning system (TCP SP2; Leica, Tokyo, Japan).

Measurement of alkaline phosphatase activity

MC3T3-E1 cells were subcultured in 12-well plates (3.8 cm2/well) in α-MEM containing 10% fetal bovine serum, 5 mM β-glycerophosphate, and 50 μg mL−1 ascorbic acid. After the cells had reached confluence (day 3), 4-HD was added to cultures at various concentrations for 9 days. Cells were washed with 10 mM Tris–HCl, pH 7.2, and were sonicated in 1 mL of 50 mM Tris–HCl (pH 7.2) containing 0.1% Triton X-100 and 2 mM MgCl2 for 15 s with a sonicator (Ultrasonic Disruptor UD-201; Tomy Co., Tokyo, Japan). Alkaline phosphatase activity was determined using an established technique with p-nitrophenyl phosphate as the substrate. Protein concentrations were determined using BCA protein assay reagent (Pierce Chemical Co., Rockford, IL, USA) with bovine serum albumin as a standard.

Quantitation of calcium deposition

MC3T3-E1 cells were subcultured in α-MEM containing 10% fetal bovine serum, 5 mM β-glycerophosphate, and 50 μg mL−1 ascorbic acid. After the cells had reached confluence (day 3), 4-HD was added at various concentrations to the culture medium and cells were subcultured for 11 days. The amount of calcium, deposited as hydroxyapatite in the cell layer, was measured as follows: Layers of cells in 12-well plates (3.8 cm2/well) were washed with PBS and incubated overnight with 1 mL of 2 N HCl with gentle shaking. Ca2+ ions in the samples were quantitated by the o-cresolphthalein complexone method with a Calcium C kit (Wako Pure Chemical Industries). This kit is specific for Ca2+ ions and has a detection limit of 1 μg mL−1. The solution of Ca2+ ions (20 mg dL−1) provided in the kit was used as the standard solution.

Real-time polymerase-chain-reaction (PCR)

The mRNA expression of RANKL and M-CSF in ST2 cells treated with 100 nM 1α, 25(OH)2 vitamin D3 was examined by real-time PCR. The RNeasy Mini Kit (Qiagen K.K., Tokyo, Japan) was used to extract RNA from cells that had been exposed to 4-HD for 2 days. Total RNA (1 μg) was reverse transcribed using the Transcriptor First Strand cDNA Synthesis Kit (Roche, Tokyo, Japan) with random primers in a 20-μL reaction mixture according to the manufacturer’s protocol. Quantitative polymerase chain reaction analysis was performed with LightCycler 480 System II (Roche) and LightCycler 480 SYBR Green I Master (Roche). PCR (95 °C for 10 s, 55 °C for 10 s, and 72 °C for 10 s, for 45 cycles) was performed using specific primers (sense primer, 5′-TGTACTTTCGAGCGCAGATG-3′, and antisense primer, 5′-CCCACAATGTGTTGCAGTTC-3′) for mouse RANKL, (sense primer, 5′-TTGCCAAGGAGGTGTCAGAA-3′, and antisense primer, 5′-TATTGGAGAGTTCCTGGAGC-3′) for mouse M-CSF, and (sense primer, 5′-ACTTTGTCAAGCTCATTT-3′, and antisense primer, 5′-TGCAGCGAACTTTATTG-3′) for mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH). GAPDH was used as an internal standard for normalization of each sample.

Statistical analysis

Numerical data have been expressed as mean ± S.D. values of the results from three to four cultures, and the significance of differences was analyzed by using ANOVA (Dunnett’s test) or Tukey–kramer. Statistical significance was set at P < 0.05. Experiments were repeated independently in triplicate and the results were qualitatively identical in every case. Results from representative experiments are shown.

Results

Toxicity of 4-HD

We evaluated the toxicity of 4-HD for MC3T3-E1 cells and ST2 cells by using the MTT assay. As shown in Fig. 2, the viability of MC3T3-E1 cells and ST2 cells was significantly increased and decreased at some concentrations. However, its disparity is not great. Furthermore, exposure of MC3T3-E1 cells and ST2 cells to 4-HD at 10 μM did not affect cell morphological features (data not shown).
Fig. 2

Effects of 4-HD on osteoblastic cell viability. MC3T3-E1 cells and ST2 cells (each 2.5 × 103 cells/well; 96-well plates) were exposed to 4-HD at various concentrations (1–10 μM) and were subcultured for indicated periods. After treatment with 4-HD, the cells were treated with MTT (50 μg/well) for 4 h, and the absorbance at 570 nm was measured. The values represent the mean ± S.D. of results from three wells. Data are representative of results from three separate experiments. *P < 0.05 versus vehicle (V) and **P < 0.01 versus V

Effects of 4-HD on the formation of multinucleated osteoclasts

Multinucleated osteoclastic cells were formed from mouse splenic cells in co-culture with ST2 cells which had been stimulated by 1α, 25(OH)2 vitamin D3. Figure 3a shows representative results for the detection of TRAP activity in multinucleated osteoclastic cells treated with 4-HD at the indicated concentrations. Formation of TRAP-positive multinucleated osteoclastic cells was dose-dependently inhibited by the addition of 4-HD (Fig. 3b). Exposure of 10 μM 4-HD completely inhibited the formation of multinucleated osteoclastic cells relative to control cultures treated with the vehicle alone.
Fig. 3

Effects of 4-HD on osteoclast formation. Osteoclasts were formed from mouse spleen cells. a Typical results of staining for the detection of TRAP activity. 4-HD was added to cultures at the indicated concentrations. Cultured cells were then stained for TRAP activity on day 7. Bar = 5 mm. b 4-HD was added to cultures at the indicated concentrations. Cultured cells were then stained for TRAP activity on day 7. TRAP-positive multinucleated cells (five or more nuclei) were counted under a microscope. Columns and bars show mean ± S.D. values of the results from five wells. Data are representative of the results of three separate experiments. *P < 0.05 versus vehicle (V), **P < 0.01 versus vehicle (V)

Real-time PCR revealed that 4-HD treatment of ST2 cells dose-dependently decreased RANKL mRNA expression (Fig. 4a). 4-HD also affected M-CSF mRNA expression (Fig. 4b).
Fig. 4

Effects of 4-HD on mRNA expression of RANKL (a) and M-CSF (b) by Real-time PCR. The RNeasy Mini Kit was used to extract RNA from ST2 cells that had been exposed to 4-HD for 2 days. The PCR conditions are described in the Materials and methods. Data are representative of results from two separate experiments. Vehicle was represented as 1

Effects of 4-HD on cultured osteoblasts

To assess the effects of 4-HD on the differentiation and mineralization of MC3T3-E1 cells, we added 4-HD to the culture medium of post-proliferative cells and assayed alkaline phosphatase activity (a middle-stage marker of osteoblastic differentiation) and calcium deposition (Fig. 5). 4-HD significantly increased the activity of alkaline phosphatase in MC3T3-E1 cells on day 9 when used at 10 μM (Fig. 5a). Furthermore, as demonstrated in Fig. 5b, 4-HD dose-dependently enhanced the deposition of calcium by MC3T3-E1 cells on day 11. Exposure of MC3T3-E1 cells to 10 μM 4-HD increased the deposition of calcium by approximately 270% on day 11, relative to control cultures treated with the vehicle alone (Fig. 5b).
Fig. 5

Effects of 4-HD on alkaline phosphatase activity and mineralization of osteoblasts. MC3T3-E1 cells were cultured in 12-well plates (3.8 cm2/well) with α-MEM containing 10% fetal bovine serum, 5 mM β-glycerophosphate, and 50 μg mL−1 ascorbic acid. After the cells reached confluence (day 3), 4-HD was added at various concentrations (1–10 μM) to the culture medium. Fresh medium with test compound was supplied at 3-days intervals. a Alkaline phosphatase activity was measured at day 9 as described in the method. b Deposition of Ca2+ ions was measured at day 11. Quantitative analysis of Ca2+ ions was performed as described in the method. All values represent the mean ± S.D. of the results from three wells. Data are representative of results from three separate experiments. *P < 0.05 versus vehicle (V) and **P < 0.01 versus V

It has been reported that hydrogen peroxide (H2O2) suppressed the differentiation of osteoblasts. Therefore, we examined the effects of 4-HD on H2O2 levels in MC3T3-E1 cells (Fig. 6). As shown in Fig. 6, 4-HD at 1 μM decreased H2O2 levels in cells.
Fig. 6

Effect of 4-HD on intracellular reactive oxygen species concentrations. Cells were pre-treated with or without 4-HD (1–10 μM) for 48 h followed by the incubation with 500 μM H2O2. Intracellular reactive oxygen species concentrations were assessed as described in the materials and methods. Data are mean ± S.E. of three to four separate experiments. **P < 0.01 versus control cells (vehicle)

Discussion

We screened natural polyphenols for the ability to regulate the proliferation, differentiation, and function of cultured osteoclasts and osteoblasts in order to identify factors that may cause, prevent, or treat bone metabolic diseases such as osteoporosis and osteopetrosis. We had previously reported that genistein attenuates osteoclastogenesis by decreasing the levels of receptor activator NF-κB ligand mRNA in osteogenic/stromal cells (Yamagishi et al. 2001). Quercetin (Notoya et al. 2004) and curcumin (Notoya et al. 2006) have been reported to inhibit cultured osteoblast metabolism. In addition, quercetin (Woo et al. 2004) and carnosic acid (Hagiwara et al. 2015) have been found to inhibit osteoclastogenesis. Recently, we showed that the olive polyphenols oleuropein and hydroxytyrosol (Hagiwara et al. 2011) and apigenin (Goto et al. 2015) inhibit the formation of osteoclasts and attenuate bone loss in OVX mice. Thus, polyphenols regulate bone metabolism in culture via osteoclasts and osteoblasts.

In this study, we attempted to clarify the potential effects of 4-HD on bone metabolism. We found that 4-HD attenuated osteoclast formation a part through the decrease in expression of RANKL and M-CSF mRNAs and induced osteoblast differentiation markers such as alkaline phosphatase activity and calcium deposition by MC3T3-E1 osteoblasts. These findings indicate that 4-HD has properties of down-regulation of osteoclastogenesis and up-regulation of osteoblastogenesis in vitro.

It is well known that polyphenols have antioxidant properties (Rice-Evans et al. 1995). Recent reports have suggested that reactive oxygen species (ROS) play an important role in the regulation of cell proliferation, differentiation and metabolism. In particular, ROS inhibit the formation of bone by osteoblastic cells (Hosoya et al. 1998; Lee et al. 2006; Mody et al. 2001). Oxidative stress resulting in increased levels of intracellular ROS has been reported to suppress bone metabolism. Arai et al. (2007) reported that mineralization of MC3T3-E1 cells was reduced by half after a single exposure to H2O2 within the non-toxic concentration range. In addition, there have been some reports that H2O2 suppresses differentiation markers such as alkaline phosphatase activity, type I collagen gene expression, and the mineralization of osteoblastic cells (Hosoya et al. 1998; Lee et al. 2006; Mody et al. 2001). We also reported that carnosic acid attenuated H2O2 levels and osteoblastic differentiation in osteoblastic MC3T3-E1 cells (Hagiwara et al. 2015). In the present study, 4-HD significantly reduced intracellular H2O2 level of MC3T3-E1 cells. These results suggest that 4-HD induces osteoblastic differentiation a part through the decrease in intracellular H2O2 level of MC3T3-E1 cells.

Ashitaba, a perennial herb growing mainly along the Pacific coast of Japan, has been used in traditional food and medicine (Baba et al. 1998). Our results using cultured cells suggest that 4-HD may be effective on bone maintenance, if 4-HD was absorbed into the plasma. It was reported that 4-HD was quickly absorbed into the plasma after oral administration of Ashitaba extract in mice (Nakamura et al. 2012). The concentration of free 4-HD reached 1.2 ± 0.3 μM in plasma at 2 h after oral administration of Ashitaba extract at 200 mg/kg body weight. This concentration is enough to be effective on inhibition of osteoclast formation and induction of osteoblast differentiation from our results.

In conclusion, polyphenol 4-HD extracted from Angelica keiskei (Ashitaba) markedly inhibited the formation of multinucleated osteoclasts in culture and induced osteoblastic differentiation. These findings suggest that 4-HD may provide insights into the development of tools useful for the prevention and treatment of osteoporosis.

Notes

Acknowledgements

This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan. We would like to thank Mrs. K. Takada for mouse maintenance.

References

  1. Akihisa T, Kikuchi T, Nagai H, Ishii K, Tabata K, Suzuki T (2011) 4-Hydroxyderricin from Angelica keiskei roots induces caspase-dependent apoptotic cell death in HL60 human leukemia cells. J Oleo Sci 60:71–77CrossRefGoogle Scholar
  2. Arai M, Shibata Y, Pugdee K, Abiko Y, Ogata Y (2007) Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life 59:27–33CrossRefGoogle Scholar
  3. Baba K, Nakata M, Taniguchi K (1998) Studies on Angelica keiskei”ashitaba”. Foods Food Ingredienis J Jpn 178:52–60Google Scholar
  4. Bredford JN, Graves SE, Smoothy CA (1993) Formation of mineralized nodules by bone derived cells in vitro: a model of bone formation? Am J Med Genet 45:163–178CrossRefGoogle Scholar
  5. Enoki T, Ohnogi H, Nagamine K, Kudo Y, Sugiyama K, Tanabe M, Kobayashi E, Sagawa H, Kato I (2007) Antidiabetic activities of chalcones isolated from a Japanese Herb, Angelica keiskei. J Agric Food Chem 55:6013–6017CrossRefGoogle Scholar
  6. Goto T, Hagiwara K, Shirai N, Yoshida K, Hagiwara H (2015) Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice. Cytotechnology 67:357–365CrossRefGoogle Scholar
  7. Hagiwara H, Inoue A, Yamaguchi A, Yokose S, Furuya M, Tanaka S, Hirose S (1996) cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. Am J Physiol 270:C1311–C1318CrossRefGoogle Scholar
  8. Hagiwara H, Sugizaki T, Tsukamoto Y, Seno E, Goto T, Ishihara Y (2008) Effects of arkylphenols on bone metabolism in vivo and in vitro. Toxicol Lett 181:13–18CrossRefGoogle Scholar
  9. Hagiwara K, Goto T, Araki M, Miyazaki H, Hagiwara H (2011) Olive polyphenol hydroxytyrosol prevents bone loss. Eur J Pharmacol 662:78–84CrossRefGoogle Scholar
  10. Hagiwara H, Basnet R, Wiyasihati SI, Nakata K, Hagiwara K, Miyazaki H, Yoshida K (2015) Carnosic acid inhibits the formation of osteoclasts through attenuation of expression of RANKL. PharmaNutrition 3:1–6CrossRefGoogle Scholar
  11. Hosoya S, Suzuki H, Yamamoto M, Kobayashi K, Abiko Y (1998) Alkaline phosphatase and type I collagen gene expressions were reduced by hydroxyl radical-treated fibronectin substratum. Mol Genet Metabol 65:31–34CrossRefGoogle Scholar
  12. Kimura Y, Taniguchi M, Baba K (2004) Antitumor and antimetastatic activities of 4-hydroxyderricin isolate from Angelica keiskei roots. Planta Med 70:211–219CrossRefGoogle Scholar
  13. Lee DH, Lim BS, Lee YK, Yang HC (2006) Effects of hydrogen peroxide (H2O2) on alkaline phosphatase activity and matrix mineralization of odontoblast and osteoblast cell lines. Cell Biol Toxicol 22:39–46CrossRefGoogle Scholar
  14. Li Y, Goto T, Yamakuni K, Takahashi H, Takahashi N, Jheng HE, Nomura W, Taniguchi M, Baba K, Murakami S, Kawada T (2016) 4-Hydroxyderricin, as a PPARγ agonist, promotes adipogenesis, adiponection secretion, and glucose uptake in 3T3-L1 cells. Lipids 51:787–795CrossRefGoogle Scholar
  15. Liu F, Malaval L, Gupta AK, Aubin JE (1994) Simultaneous detection of multiple bone-related mRNAs and protein expression during osteoblast differentiation: polymerase chain reaction and immunocytochemical studies at the single cell level. Dev Biol 166:220–234CrossRefGoogle Scholar
  16. Mody N, Parhami F, Sarafian TA, Demer LL (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509–519CrossRefGoogle Scholar
  17. Nakamura T, Tokushima T, Kawabata K, Yamamoto N, Miyamoto M, Ashida H (2012) Absorption and metabolism of 4-hydroxyderricin and xanthoangelol after oral administration of Angelica keiskei (Ashitaba) extract in mice. Arch Biochem Biophys 521:71–76CrossRefGoogle Scholar
  18. Notoya M, Tsukamoto Y, Nishimura H, Woo J-T, Nagai K, Lee I-S, Hagiwara H (2004) Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteoblasts in vitro. Eur J Pharmacol 485:89–96CrossRefGoogle Scholar
  19. Notoya M, Nishimura H, Woo J-T, Nagai K, Ishihara Y, Hagiwara H (2006) Curcumin inhibits the proliferation and mineralization of cultured osteoblasts. Eur J Pharmacol 534:55–62CrossRefGoogle Scholar
  20. Notoya M, Arai R, Katafuchi T, Minamino N, Hagiwara H (2007) A novel member of the calcitonin gene-related peptide family, calcitonin receptor-stimulating peptide, inhibits the formation and activity of osteoclasts. Eur J Pharmacol 560:234–239CrossRefGoogle Scholar
  21. Okuyama T, Takata M, Takayasu J, Hasegawa T, Tokuda H, Nishino A, Nishino H, Iwashima A (1991) Anti-tumor-promotion by principles obtained from Angelica keiskei. Planta Med 57:242–246CrossRefGoogle Scholar
  22. Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB (1995) The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 22:375–383CrossRefGoogle Scholar
  23. Stein GS, Lian JB, Owen TA (1990) Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4:3111–3123CrossRefGoogle Scholar
  24. Sumiyoshi M, Taniguchi M, Baba K, Kimura Y (2015) Antitumor and antimetastatic actions of xanthoangelol and 4-hydroxyderricin isolated from Angelica keiskei roots though the inhibited activation and differentiation of M2 macrophages. Phytomedcine 22:759–767CrossRefGoogle Scholar
  25. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87:7260–7264CrossRefGoogle Scholar
  26. Woo J-T, Nakagawa H, Notoya M, Yonezawa T, Udagawa N, Lee I-S, Ohnishi M, Hagiwara H, Nagai K (2004) Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Biol Pharm Bull 27:504–509CrossRefGoogle Scholar
  27. Yadav VR, Prasad S, Sung B, Aggarwal BB (2011) The role of chalcones in suppression of NF-κB-mediated inflammation and cancer. Int Immunopharmacol 11:295–309CrossRefGoogle Scholar
  28. Yamagishi T, Otsuka E, Hagiwara H (2001) Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis. Endocrinology 142:3632–3637CrossRefGoogle Scholar
  29. Yasuda M, Kawabata K, Miyashita M, Okumura M, Yamamoto N, Takahashi M, Ashida H, Ohigashi H (2014) J Agric Food Chem 62:462–467CrossRefGoogle Scholar
  30. Zhang T, Yamashita Y, Yasuda M, Yamamoto N, Ashida H (2015) Ashitaba (Angelica keiskei) extract prevents adiposity in high-fat diet-fed C57BL/6 mice. Food Funct 6:135–145Google Scholar

Copyright information

© The Author(s) 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Hiromi Hagiwara
    • 1
    Email author
  • Kyoko Nakata
    • 1
  • Hitoshi Miyazaki
    • 2
  • Sanae Maehashi
    • 1
  • Yuki Komiyama
    • 1
  • Rieko Aida
    • 1
  • Shigeki Yoshida
    • 2
  • Daichi Kokubu
    • 2
  • Keitaro Hagiwara
    • 3
  • Kaoru Yoshida
    • 1
  1. 1.Faculty of Biomedical EngineeringToin University of YokohamaYokohamaJapan
  2. 2.Faculty of Life and Environmental SciencesUniversity of TsukubaTsukubaJapan
  3. 3.Healthcare Systems Co., LtdNagoyaJapan

Personalised recommendations